Posted inWellness
New medicine may help reduce infant hospitalisations during RSV season
Sanofi today announced that the South African Health Products Regulatory Authority (SAHPRA) has granted registration for a long-acting monoclonal antibody (mAb) designed to protect infants against Respiratory Syncytial Virus (RSV), one of the…

